02072nam a2200409 i 4500001001300000003000600013005001700019007001400036008004100050040003000091042000800121043001200129074001600141086002200157088010100179110008500280245027100365246006000636264006000696300002700756336000800783337001600791338001900807500002500826500003600851500002500887504004100912533010600953776018701059776017001246050002101416610006001437650003301497650006601530650003301596655003301629on1090141957OCoLC20190416103930.0he bmb024bbca190319s2018    dcu     bb   f000 0 eng c  aPUCPRbengerdacGPOdMvI  apcc  an-us---  a1016-B (MF)0 aY 4.G 74/7:115-82  aSerial no. 115-82 (United States. Congress. House. Committee on Oversight and Government Reform)1 aUnited States.bCongress.bHouse.bCommittee on Oversight and Government Reform,12aA sustainable solution to the evolving opioid crisis :brevitalizing the Office of National Drug Control Policy : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fifteenth Congress, second session, May 17, 2018.30aRevitalizing the Office of National Drug Control Policy 1aWashington :bU.S. Government Publishing Office,c2018.  aiii, 72 pages ;c24 cm  btxt  bh2rdamedia  bhe2rdacarrier  a"Serial no. 115-82."  aShipping list no.: 2018-0252-M.  aCRDP Program record.  aIncludes bibliographical references.  aMicrofiche.b[Washington, D.C.] :cU.S. Government Printing Office,d[2018]e1 microfiche : negative.08iPrint version:aUnited States. Congress. House. Committee on Oversight and Government Reform.tSustainable solution to the evolving opioid crisisw(DLC) 2017415202w(OCoLC)105278335508iOnline version:aUnited States. Congress. House. Committee on Oversight and Government Reform.tSustainable solution to the evolving opioid crisisw(OCoLC)1052783431 4aKF27b.O94 2018b10aUnited States.bOffice of National Drug Control Policy. 0aOpioid abusezUnited States. 0aDrug addictionxPreventionxGovernment policyzUnited States. 0aDrug controlzUnited States. 7aLegislative hearings.2lcgft